Published in J Virol on October 16, 2013
Transfusion-Transmitted Dengue and Associated Clinical Symptoms During the 2012 Epidemic in Brazil. J Infect Dis (2015) 1.46
Utility, limitations, and future of non-human primates for dengue research and vaccine development. Front Immunol (2014) 0.86
Dengue Virus Infection of Aedes aegypti Requires a Putative Cysteine Rich Venom Protein. PLoS Pathog (2015) 0.85
Host Inflammatory Response to Mosquito Bites Enhances the Severity of Arbovirus Infection. Immunity (2016) 0.83
Parameters of Mosquito-Enhanced West Nile Virus Infection. J Virol (2015) 0.83
Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity. PLoS Negl Trop Dis (2015) 0.82
Rice ragged stunt virus-induced apoptosis affects virus transmission from its insect vector, the brown planthopper to the rice plant. Sci Rep (2015) 0.81
Mosquito Saliva Increases Endothelial Permeability in the Skin, Immune Cell Migration, and Dengue Pathogenesis during Antibody-Dependent Enhancement. PLoS Pathog (2016) 0.80
Gene expression changes in the salivary glands of Anopheles coluzzii elicited by Plasmodium berghei infection. Parasit Vectors (2015) 0.79
Discovery of mosquito saliva microRNAs during CHIKV infection. PLoS Negl Trop Dis (2015) 0.79
Dissecting vectorial capacity for mosquito-borne viruses. Curr Opin Virol (2015) 0.79
Impact of Insect Salivary Proteins in Blood Feeding, Host Immunity, Disease, and in the Development of Biomarkers for Vector Exposure. Curr Opin Insect Sci (2015) 0.78
Sialic acid expression in the mosquito Aedes aegypti and its possible role in dengue virus-vector interactions. Biomed Res Int (2015) 0.77
The human immune system's response to carcinogenic and other infectious agents transmitted by mosquito vectors. Parasitol Res (2016) 0.76
Aedes aegypti D7 Saliva Protein Inhibits Dengue Virus Infection. PLoS Negl Trop Dis (2016) 0.75
Dengue virus serotype 2 infection alters midgut and carcass gene expression in the Asian tiger mosquito, Aedes albopictus. PLoS One (2017) 0.75
Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A Hypothesis. Front Immunol (2016) 0.75
Experimental inoculation of Artibeus jamaicensis bats with dengue virus serotypes 1 or 4 showed no evidence of sustained replication. Am J Trop Med Hyg (2014) 0.75
Solute carriers affect Anopheles stephensi survival and Plasmodium berghei infection in the salivary glands. Sci Rep (2017) 0.75
Preparation of Mosquito Salivary Gland Extract and Intradermal Inoculation of Mice. Bio Protoc (2014) 0.75
Human skin Langerhans cells are targets of dengue virus infection. Nat Med (2000) 5.74
Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis (1996) 5.03
Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol (2005) 3.58
Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol (1998) 3.51
Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. PLoS Pathog (2007) 2.13
An annotated catalogue of salivary gland transcripts in the adult female mosquito, Aedes aegypti. BMC Genomics (2007) 2.06
Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J Virol (2001) 1.94
Function and evolution of a mosquito salivary protein family. J Biol Chem (2005) 1.90
The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response. Trans R Soc Trop Med Hyg (2008) 1.88
Dengue structure differs at the temperatures of its human and mosquito hosts. Proc Natl Acad Sci U S A (2013) 1.75
Potentiation of West Nile encephalitis by mosquito feeding. Viral Immunol (2006) 1.62
A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads. J Virol (2008) 1.59
The Drosophila Stubble-stubbloid gene encodes an apparent transmembrane serine protease required for epithelial morphogenesis. Proc Natl Acad Sci U S A (1993) 1.54
West Nile Virus: biology, transmission, and human infection. Clin Microbiol Rev (2012) 1.38
Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. J Virol (2012) 1.36
In vitro activation of pro-phenol-oxidase by two kinds of pro-phenol-oxidase-activating factors isolated from hemolymph of coleopteran, Holotrichia diomphalia larvae. Eur J Biochem (1998) 1.32
Alpha 6 integrins are required for Langerhans cell migration from the epidermis. J Exp Med (1997) 1.32
Mosquito saliva causes enhancement of West Nile virus infection in mice. J Virol (2010) 1.30
Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity. J Virol (2012) 1.25
Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West Nile virus infection. PLoS One (2007) 1.21
Complex modulation of the Aedes aegypti transcriptome in response to dengue virus infection. PLoS One (2012) 1.17
A simple method for determining arbovirus transmission in mosquitoes. J Am Mosq Control Assoc (2010) 1.16
Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus. PLoS One (2010) 1.09
Sialokinin I and II: vasodilatory tachykinins from the yellow fever mosquito Aedes aegypti. Proc Natl Acad Sci U S A (1994) 1.07
Saliva of the Yellow Fever mosquito, Aedes aegypti, modulates murine lymphocyte function. Parasite Immunol (2004) 1.04
CLIP-domain serine proteases in Drosophila innate immunity. BMB Rep (2008) 1.04
Modulation of dengue virus infection of dendritic cells by Aedes aegypti saliva. Viral Immunol (2004) 1.02
Association of human immune response to Aedes aegypti salivary proteins with dengue disease severity. Parasite Immunol (2012) 0.99
A factor Xa-directed anticoagulant from the salivary glands of the yellow fever mosquito Aedes aegypti. Exp Parasitol (1995) 0.98
An insight into the sialotranscriptome of the West Nile mosquito vector, Culex tarsalis. BMC Genomics (2010) 0.94
Differential expression of Aedes aegypti salivary transcriptome upon blood feeding. Parasit Vectors (2009) 0.90
Aedes aegypti saliva contains a prominent 34-kDa protein that strongly enhances dengue virus replication in human keratinocytes. J Invest Dermatol (2013) 0.88
Irritant-induced migration of Langerhans cells coincides with an IL-10-dependent switch to a macrophage-like phenotype. J Invest Dermatol (2010) 0.86
A new factor in the Aedes aegypti immune response: CLSP2 modulates melanization. EMBO Rep (2011) 0.86
Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol (2006) 0.85
Subtoxic concentrations of allergenic haptens induce LC migration and maturation in a human organotypic skin explant culture model: a novel method for identifying potential contact allergens. Exp Dermatol (2006) 0.83
Haemolytic activity in the blood clot of Aedes aegypti. Acta Trop (1975) 0.79
Mutational analysis of Stubble-stubbloid gene structure and function in Drosophila leg and bristle morphogenesis. Genetics (2005) 0.78
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell (2009) 7.88
Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med (2004) 7.49
RNA interference screen for human genes associated with West Nile virus infection. Nature (2008) 4.93
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature (2010) 3.49
STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci U S A (2003) 3.46
The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity (2012) 3.43
OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest (2004) 3.38
Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J Exp Med (2004) 3.02
The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature (2005) 2.82
Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med (2002) 2.77
Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity (2009) 2.66
Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol (2010) 2.63
TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell (2004) 2.62
Host feeding patterns of Culex mosquitoes and West Nile virus transmission, northeastern United States. Emerg Infect Dis (2006) 2.58
Molecular adaptation of Borrelia burgdorferi in the murine host. J Exp Med (2002) 2.49
Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol (2007) 2.46
Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J Virol (2006) 2.20
Age-associated defect in human TLR-1/2 function. J Immunol (2007) 2.20
A tick antioxidant facilitates the Lyme disease agent's successful migration from the mammalian host to the arthropod vector. Cell Host Microbe (2007) 2.17
Epidemiology of West Nile virus in Connecticut: a five-year analysis of mosquito data 1999-2003. Vector Borne Zoonotic Dis (2004) 2.15
Rab 5 is required for the cellular entry of dengue and West Nile viruses. J Virol (2007) 2.12
Human Borrelia miyamotoi infection in the United States. N Engl J Med (2013) 2.11
Silent substitutions predictably alter translation elongation rates and protein folding efficiencies. J Mol Biol (2012) 2.04
IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J Immunol (2003) 2.03
Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol (2009) 2.00
Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol (2008) 1.93
DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses. J Virol (2003) 1.91
Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol (2006) 1.84
Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun (2004) 1.82
Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma. Mol Cancer (2014) 1.81
West Nile virus: a growing concern? J Clin Invest (2004) 1.77
Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis (2002) 1.75
Salp15, an ixodes scapularis salivary protein, inhibits CD4(+) T cell activation. Immunity (2002) 1.75
A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in Europe. Lancet (2013) 1.73
Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus. J Virol (2005) 1.72
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine (2009) 1.72
A viral RNA structural element alters host recognition of nonself RNA. Science (2014) 1.71
Slowing bacterial translation speed enhances eukaryotic protein folding efficiency. J Mol Biol (2010) 1.70
Yellow fever: a reemerging threat. Clin Lab Med (2010) 1.69
A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. J Infect Dis (2007) 1.68
Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Microbiol (2003) 1.65
Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay. J Clin Microbiol (2004) 1.59
Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J Clin Invest (2007) 1.57
Disruption of Ixodes scapularis anticoagulation by using RNA interference. Proc Natl Acad Sci U S A (2004) 1.56
Effects of PKR/RNase L-dependent and alternative antiviral pathways on alphavirus replication and pathogenesis. Viral Immunol (2002) 1.56
Vapor-phase self-assembled monolayer for improved mold release in nanoimprint lithography. Langmuir (2005) 1.55
Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection. Infect Immun (2004) 1.52
Repression of rac2 mRNA expression by Anaplasma phagocytophila is essential to the inhibition of superoxide production and bacterial proliferation. J Immunol (2002) 1.52
Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Infect Immun (2006) 1.52
Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing. J Infect Dis (2013) 1.51
Circuit fabrication at 17 nm half-pitch by nanoimprint lithography. Nano Lett (2006) 1.51
Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol (2008) 1.49
Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis. J Virol (2008) 1.48
Salivating for knowledge: potential pharmacological agents in tick saliva. PLoS Med (2008) 1.46
Host responses to alphavirus infection. Immunol Rev (2008) 1.46
A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the lyme disease agent. Cell Host Microbe (2011) 1.44
The Lyme disease agent Borrelia burgdorferi requires BB0690, a Dps homologue, to persist within ticks. Mol Microbiol (2006) 1.44
Salp15 binding to DC-SIGN inhibits cytokine expression by impairing both nucleosome remodeling and mRNA stabilization. PLoS Pathog (2008) 1.43
Examination of the Borrelia burgdorferi transcriptome in Ixodes scapularis during feeding. J Bacteriol (2002) 1.43
Adaptation of Borrelia burgdorferi in the vector and vertebrate host. Microbes Infect (2003) 1.41
Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging Cell (2011) 1.39
Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15. J Immunol (2006) 1.39
West Nile Virus: biology, transmission, and human infection. Clin Microbiol Rev (2012) 1.38
Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis (2011) 1.38
A paradoxical role for neutrophils in the pathogenesis of West Nile virus. J Infect Dis (2010) 1.37
IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog (2009) 1.35
Invasion and survival strategies of Anaplasma phagocytophilum. Cell Microbiol (2003) 1.35
Tick-host-pathogen interactions in Lyme borreliosis. Trends Parasitol (2007) 1.34
A recombinant envelope protein vaccine against West Nile virus. Vaccine (2005) 1.31
Association of linear plasmid 28-1 with an arthritic phenotype of Borrelia burgdorferi. Infect Immun (2005) 1.30
Protective niche for Borrelia burgdorferi to evade humoral immunity. Am J Pathol (2004) 1.29
Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. J Exp Med (2007) 1.29
Isolations of Jamestown Canyon virus (Bunyaviridae: Orthobunyavirus) from field-collected mosquitoes (Diptera: Culicidae) in Connecticut, USA: a ten-year analysis, 1997-2006. Vector Borne Zoonotic Dis (2008) 1.28
A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog (2009) 1.27
A systems approach to improving error reporting. J Healthc Inf Manag (2002) 1.27
Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver. Int J Radiat Oncol Biol Phys (2008) 1.26
West Nile virus envelope protein inhibits dsRNA-induced innate immune responses. J Immunol (2007) 1.26
Borrelia burgdorferi transcriptome in the central nervous system of non-human primates. Proc Natl Acad Sci U S A (2003) 1.26
DNA microarray assessment of putative Borrelia burgdorferi lipoprotein genes. Infect Immun (2002) 1.25
Use of RNA interference to prevent lethal murine west nile virus infection. J Infect Dis (2005) 1.24
Outer surface protein B is critical for Borrelia burgdorferi adherence and survival within Ixodes ticks. PLoS Pathog (2007) 1.24
Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses. J Virol (2007) 1.24
Postsplenectomy reactive thrombocytosis. Proc (Bayl Univ Med Cent) (2009) 1.23